Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Uterine Cervical Neoplasms × Topotecan × Clear all

Phase

Status

Completed 15 Unknown 2 Terminated 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 8 Ovarian Neoplasms 5 Retinoblastoma 3 Neuroblastoma 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 SCLC 1 Recurrence 1 Pleuropulmonary blastoma 1 Pediatric Brain Tumor 1 Neoplasms 1 Medulloblastoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Ganglioneuroblastoma 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

pembrolizumab 17 Cisplatin 14 Carboplatin 10 Bevacizumab 9 Radiotherapy 8 Paclitaxel 8 Drug Therapy 7 Colposcopy 6 Brachytherapy 6 Blood Specimen Collection 6 Specimen Handling 5 camrelizumab 4 Nivolumab 4 Injections 4 Human Papillomavirus DNA Tests 4 Gemcitabine 4 Chemotherapy, Adjuvant 4 Chemoradiotherapy 4 toripalimab 3 Taxes 3 Surveys and Questionnaires 3 Mass Screening 3 Fulvestrant 3 Cyclophosphamide 3 Biopsy 3 zimberelimab 2 spartalizumab 2 lenvatinib 2 fludarabine 2 dostarlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06459180 2026-03-13

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡